Evidence map›Paper›PMID 33207806›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-

Chiara Greco, Rosa Catania, Dario Leonardo Balacco, Vincenzo Taresco, Francesca Musumeci, Cameron Alexander, Alan Huett, Silvia Schenone

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Disclosing New Insights on Pyrazolo[3,4-Journal of microbiology and biotechnology · 2025
    Article
  3. Advances in pyrazolo[1,5-RSC advances · 2025
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Chiara GrecoDipartimento di Farmacia, Università di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.ORCID 0000-0003-1773-584X
Rosa CataniaSchool of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK.ORCID 0000-0002-4717-808X
Dario Leonardo BalaccoSchool of Dentistry, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B5 7EG, UK.ORCID 0000-0002-7648-1213
Vincenzo TarescoSchool of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Francesca MusumeciDipartimento di Farmacia, Università di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.
Cameron AlexanderSchool of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Alan HuettSchool of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK.ORCID 0000-0001-7385-5585
Silvia SchenoneDipartimento di Farmacia, Università di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.
University of Nottingham · GBUniversity of Genoa · ITUniversity of Birmingham · GB

Funding

Engineering and Physical Sciences Research Council EP/N50970X/1 EP/N03371X/1Royal Society Wolfson Research Merit Award WM150086
6 · The paper itself

Abstract

Pyrazolo[3,4-

Indexed as

Anti-Bacterial AgentsEscherichia coliMicrobial Sensitivity TestsPhylogenyProtein DomainsProtein Kinase InhibitorsProtein KinasesPyrazolesStaphylococcus aureusAnti-Bacterial AgentsProtein Kinase InhibitorsProtein KinasesPyrazolesantimicrobialskinase inhibitorspyrazolo[3,4-d]pyrimidinesβ-lactam antibiotics

Identifiers

PMID33207806
PMCPMC7696985
OpenAlexW3098381312

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.